학술논문
41916 Lebrikizumab reduced interference of itch on sleep at 52 weeks in patients with moderate-to- severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
Document Type
Abstract
Author
Source
In Journal of the American Academy of Dermatology September 2023 89(3) Supplement:AB61-AB61
Subject
Language
ISSN
0190-9622